Nashik civic body to sterilize stray cats, gets general body's nod
The civic body plans to extend its animal birth control (ABC) programme, currently operational for stray dogs, to include the sterilisation of stray cats.
The general body of the Nashik Municipal Corporation (NMC) has approved the administration's proposal to commence cat sterilisation and engage an agency for capturing and sterilising stray cats. This aligns with the Prevention of Cruelty of Animals Act, 1960, and the Animal Birth Control (Dogs) Rules, 2022, which mandate stray cat population control. State govt previously issued relevant guidelines through a circular.
Over the past decade, NMC has successfully sterilised 80,000 stray dogs. Their teams respond to complaints about stray dogs, avoiding those already sterilised. Post-procedure, the dogs return to their original locations.
The appointed agency for cat sterilisation will need to establish necessary facilities, including an operation theatre, a dedicated cat ward, and essential utilities like water and electricity.
The initial contract period is set for one year, with an estimated cost of Rs 20 lakh, funded under the stray animal sterilisation budget. NMC has allocated Rs 3.5 crore in its budget for the financial year 2025-26.
Following the general body's approval, NMC officials confirm they will issue tenders for a private agency to conduct cat sterilisation. The selected agency's teams will capture stray cats, perform sterilisation procedures, and return them to their original locations.
Nashik: The civic body is initiating a dedicated sterilisation programme to control the increasing stray cat population within its jurisdiction.
The civic body plans to extend its animal birth control (ABC) programme, currently operational for stray dogs, to include the sterilisation of stray cats.
The general body of the Nashik Municipal Corporation (NMC) has approved the administration's proposal to commence cat sterilisation and engage an agency for capturing and sterilising stray cats.
This aligns with the Prevention of Cruelty of Animals Act, 1960, and the Animal Birth Control (Dogs) Rules, 2022, which mandate stray cat population control. State govt previously issued relevant guidelines through a circular.
Over the past decade, NMC has successfully sterilised 80,000 stray dogs. Their teams respond to complaints about stray dogs, avoiding those already sterilised. Post-procedure, the dogs return to their original locations.
The appointed agency for cat sterilisation will need to establish necessary facilities, including an operation theatre, a dedicated cat ward, and essential utilities like water and electricity. The initial contract period is set for one year, with an estimated cost of Rs 20 lakh, funded under the stray animal sterilisation budget. NMC has allocated Rs 3.5 crore in its budget for the financial year 2025-26.
Following the general body's approval, NMC officials confirm they will issue tenders for a private agency to conduct cat sterilisation. The selected agency's teams will capture stray cats, perform sterilisation procedures, and return them to their original locations.
Follow more information on
Air India plane crash in Ahmedabad here
. Get
real-time live updates
on rescue operations and check
full list of passengers onboard AI 171
.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
40 minutes ago
- Time of India
FCIMS recognition cancelled by NMC
Representative image HYDERABAD: The National Medical Commission (NMC) has revoked the recognition of Father Colombo Institute of Medical Sciences (FCIMS) in Warangal, a private medical college with 150 seats, following bribery allegations against one of its trustees in a nationwide scam involving the recognition of private medical institutions. This action follows a case filed by the CBI against Father Joseph Komareddy, who allegedly attempted to pay 66 lakh to NMC officials during an annual inspection concerning infrastructure and faculty requirements for regulatory approval. The move is part of a broader CBI investigation into corruption within the NMC. The probe has uncovered a network of intermediaries accused of securing approvals for private medical colleges through bribery. A total of 36 individuals have been named in the FIR, including two from Telangana, one based in Hyderabad, Ankam Rambabu, and another trustee of FCIMS. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad According to health department officials, although FCIMS's recognition has been withdrawn, students currently enrolled in the first and second years of MBBS programme will be permitted to continue their studies. Of the 30 medical colleges in Telangana, two are deemed universities, one has had its recognition revoked, and the admissions process for the remaining 27 private colleges will be overseen by Kaloji Narayana Rao University of Health Sciences (KNRUHS).
Hans India
an hour ago
- Hans India
CMRF cheques worth Rs 42 lakh distributed
Guntur: Union Minister of State for Rural Development and Communications, Dr Pemmasani Chandrasekhar said the government led by Chief Minister N Chandrababu Naidu is committed to the welfare of the poor and weaker sections. Through the Chief Minister's Relief Fund timely assistance is being provided, bringing hope and relief to the lives of the poor, he said. He distributed financial assistance from the CMRF cheques worth Rs 42,14,861 to poor beneficiaries at a programme held at his camp office here on Sunday. He stated that the programme reflects the government's commitment to welfare and such assistance offers great relief in times of medical emergencies or financial distress. It reflects the compassionate vision Chief Minister Nara Chandrababu Naidu holds for the underprivileged. The CMRF distribution is a crucial part of the CM's efforts to ensure government services reach all sections of society. The government's efforts to safeguard public health are being widely appreciated, he said.
Time of India
4 hours ago
- Time of India
Anthem Biosciences IPO listing today. Check GMP ahead of debut
Anthem Biosciences is set to debut on the stock exchanges on Monday after a highly subscribed IPO that raised Rs 3,396 crore entirely through an offer for sale. The company, one of India's leading contract research and manufacturing organisations (CRDMOs), had fixed its issue price at Rs 570 per share. Ahead of listing, the stock is commanding a grey market premium (GMP) of around 30%, suggesting investor enthusiasm despite a rich valuation. Explore courses from Top Institutes in Select a Course Category Healthcare healthcare Data Science Technology Project Management Cybersecurity Public Policy Leadership PGDM MCA Data Science Management Finance CXO Operations Management Data Analytics Product Management MBA Others Design Thinking Digital Marketing Degree Artificial Intelligence others Skills you'll gain: Financial Analysis in Healthcare Financial Management & Investing Strategic Management in Healthcare Process Design & Analysis Duration: 12 Weeks Indian School of Business Certificate Program in Healthcare Management Starts on Jun 13, 2024 Get Details The IPO, which opened between July 14 and 16, received a strong response across categories, with the overall subscription reaching 67.4 times. Qualified institutional buyers (QIBs) led the charge, subscribing 192.8 times their allotted quota. Non-institutional investors followed with a 44.7 times bid, while the retail category was booked nearly 6 times. Anthem's issue had no fresh component, and the proceeds will go entirely to selling shareholders. Anchor investors had already pumped in Rs 1,016 crore prior to the IPO opening. Founded in 2006, Anthem operates across the drug development lifecycle—discovery, development, and commercial manufacturing—for both small molecules and biologics. Live Events With 196 projects underway, a global customer base across 44 countries, and a growing portfolio of fermentation-based APIs and specialty ingredients, the company has carved a niche in India's pharma value chain. In FY25, Anthem reported a 30% rise in revenue to Rs 1,930 crore and a 23% growth in net profit to Rs 451 crore. EBITDA came in at Rs 684 crore with a strong margin of nearly 37%, while debt levels remained low. With solid financials, a high-margin model, and a leadership position in the CRDMO space, all eyes will now be on Anthem's market debut. A GMP of 30% points to a likely premium listing, but given the steep valuation, the street will closely track its post-listing performance and growth trajectory. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
